Tandem Diabetes Care(GB:0M0F)
$18.38-0.54 (-2.85%)
GB:0M0F
Tandem Diabetes Care ownership
$18.38
At close:-0.54 (-2.85%)
Tandem Diabetes Care (0M0F) Ownership - Who Owns Tandem Diabetes Care?
6 Followers
Tandem Diabetes Care (0M0F) Ownership Overview
- 1.00% Insiders
- 20.54% Mutual Funds
- 11.24% Other Institutional Investors
- 27.05% ETFs
- 40.18% Public Companies and Individual Investors
The ownership structure of Tandem Diabetes Care (GB:0M0F) stock is a mix of institutional, retail, and individual investors. Approximately 58.82% of the company’s stock is owned by Institutional Investors, 1.00% is owned by Insiders, and 40.18% is owned by Public Companies and Individual Investors.
The ownership structure of Tandem Diabetes Care (GB:0M0F) stock is a mix of institutional, retail, and individual investors. Approximately 58.82% of the company’s stock is owned by Institutional Investors, 1.00% is owned by Insiders, and 40.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Entrypoint Capital, Llc | $208,304 | |
| Dec 31, 2025 | Deerfield Management Company, Lp | $573,458 | |
| Dec 31, 2025 | Royce & Associates Llc | $14,292,495 | |
| Dec 31, 2025 | Driehaus Capital Management Llc | $35,395,317 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 11,583,125 | Institution | 16.60% | 219,152,725 |
| Ishares | 8,119,198 | Institution | 11.63% | 153,615,226 |
| Vanguard | 6,469,762 | Institution | 9.27% | 122,407,897 |
| Vanguard Index Funds | 5,446,913 | Institution | 7.80% | 103,055,594 |
| Steve Weber | 1,786,996 | Institution | 2.56% | 33,809,964 |
| Spdr | 1,430,906 | Institution | 2.05% | 27,072,742 |
| Michael Rockefeller | 1,307,439 | Institution | 1.87% | 24,736,746 |
| Fidelity | 946,290 | Institution | 1.36% | 17,903,807 |
| Meridian Fund Inc | 916,447 | Institution | 1.31% | 17,339,177 |
| Chuck Royce | 848,233 | Institution | 1.22% | 16,048,568 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 5,446,913 | Institution | 7.80% | 103,055,594 |
| Meridian Fund Inc | 916,447 | Institution | 1.31% | 17,339,177 |
| Fidelity Salem Street Trust | 839,394 | Institution | 1.20% | 15,881,334 |
| Prudential Sector Funds, Inc. | 680,031 | Institution | 0.97% | 12,866,187 |
| Fidelity Rutland Square Trust Ii | 661,203 | Institution | 0.95% | 12,509,961 |
| Fidelity Concord Street Trust | 655,586 | Institution | 0.94% | 12,403,687 |
| Amg Funds | 531,536 | Institution | 0.76% | 10,056,661 |
| Vanguard Scottsdale Funds | 482,328 | Institution | 0.69% | 9,125,646 |
| Vanguard Tax-managed Funds | 454,971 | Institution | 0.65% | 8,608,051 |
| Royce Fund | 423,694 | Institution | 0.61% | 8,016,290 |
FAQ
Who Owns Tandem Diabetes Care (GB:0M0F)?
According to the latest TipRanks data, approximately 58.82% of the company's stock is held by institutional investors, 1.00% is held by insiders, and 40.18% is held by public companies and individual investors.
What percentage of Tandem Diabetes Care (GB:0M0F) stock is held by institutional investors?
According to the latest TipRanks data, approximately 58.82% of Tandem Diabetes Care (GB:0M0F) stock is held by institutional investors: 20.54% by mutual funds, 27.05% by ETFs and 11.24% by other institutional investors.
What percentage of Tandem Diabetes Care (GB:0M0F) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.18% of Tandem Diabetes Care (GB:0M0F) stock is held by public companies and individual investors.
Who owns the most shares of Tandem Diabetes Care (GB:0M0F)?
BlackRock, Inc. owns the most shares of Tandem Diabetes Care (GB:0M0F).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
